Applied Biosystems and Sun Microsystems join forces to produce an informatics solution for Glaucus Proteomics
Glaucus Proteomics has chosen Applied Biosystems and Sun Microsystems to create an efficient bioinformatics system for its R and D and production activities at its headquarters near Utrecht, Netherlands.
Glaucus is a biotechnology company that develops antibody and protein arrays for the identification and characterisation of disease specific proteins to accelerate and optimise drug development and disease management.
In addition, Glaucus is transforming the generation of antibodies into a fast and cost-effective process.
Biocomputing represents a core element of Glaucus's activities, as do efficient solutions for management, interrogation and visualisation of complex data sets.
"The critical need for Lims implementation and an effective computing platform cannot be overestimated for the growth and development of Glaucus.
The combined solution offered by Applied Biosystems and Sun Microsystems successfully met our needs for quality assurance of production, process management, and computation for complexity analysis and data storage," explained professor Ian Humphrey Smith, chief scientific officer at Glaucus.
"The systems put in place are built upon the knowledge-base that Applied Biosystems has gained in the cDNA biochip arena, while a multi-tier server structure, inherent reliability and redundancy, availability of dynamic partitioning and unequalled internal throughput made Sun Microsystems a logical choice." "Modern technologies in the drug discovery process based on genomics and proteomics generate a massive amount of rich data and laboratories face enormous data management challenges," said Marco Piccinini, European informatics manager at Applied Biosystems.
"They need a robust laboratory information data management system that can track thousands of analyses per day through every phase of the process, collect and manage this content-rich data.
We are proud that Glaucus chose the Applied Biosystems SQL Lims software and our professional service organisation as its preferred choice to manage the data during the protein and antibody array production." Greg Stroud, vice president, Sun Microsystems (UK and Ireland), said: "We are very excited to be working with Glaucus Proteomics and Applied Biosystems in the area of protein identification.
Life science is an important sector for Sun, providing some of the largest computing and data management challenges.
We are proud to provide Glaucus with a critical solution that will help to discover, analyse and assess proteins."
